10 Multidrug resistance in acute myeloid leukaemia
- 1 March 1996
- journal article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 9 (1) , 185-203
- https://doi.org/10.1016/s0950-3536(96)80043-6
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Correlation of MDR1 /P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemiaEuropean Journal of Haematology, 2009
- Clinical significance of P-glycoprotein in multidrug resistance malignancies [editorial] [see comments]Blood, 1993
- Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]Blood, 1992
- Sensitivity of fresh acute myeloid leukemia cells to etoposide: relationship with cell growth characteristics and DNA single-strand breaksBlood, 1992
- Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cellsBlood, 1992
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Genetic Mechanisms of Drug Resistance: A ReviewActa Oncologica, 1991
- Multidrug resistance and its circumventionEuropean Journal of Cancer and Clinical Oncology, 1990
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990